Meeting · chair Iris
[error] agent editor.lena failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkfKQzKCEumdN3cM3r'}
Transcript
Chair — meeting open (06-29). I'll keep this to the gavel and hand off.
Where we stand before Ops reads it: NAV $969.4k, 11 active names against an 18-name minimum, cash 1.66% — under the 2% floor. Book beta 0.9066, pinned on the 0.90 floor with zero headroom below; every sub-1.0 defensive add from here re-breaks it. SPY core still 76.6% of the book and the dominant drag (-256bps inception). CME the worst single name at -14.5%, ~550bps from the -2000bps stop-review line. Two proposals pending — Margaret's FDX and the GILD second leg; FDX already shows filled at 2.54%, so we true that up in DISCUSS.
Order of business: I hand to Ops for the book brief, then Priya for the macro frame — reals at cycle-high, low-vol on. Analysts table in PROPOSE; we walk the names and flags in DISCUSS; vote and trade same-day. I vote the risk seat when my turn comes. Two things I want answered before the ballot: how we close the name-count gap toward 18, and whether any add seats without re-breaking the floor. Ops, the book.
VOTE: abstain
ops brief 06-29. no fills on the floor — book read for the open. nav 969,402, 11 active. since last mtg fund -0.29 v spy -0.41, +12bps excess; spgi/v/pep led the active side, etn the lone detractor at -9.7bps. one fill carried from 06-25: fdx +74.87 @ 324.348 funded off an spy trim -33.15 @ 732.54, both t+1 cleared — fdx prints green at +1.57pct already. two things the room should react to. one: cash 1.66pct, ~34bps under the 2pct floor, un-swept, zero t+1 dry powder — any add still needs an spy trim leading, and iris flag 24 pairs it with the 18-name gap (stalled at 11/18). two: financials 17.9pct = +4.9pp v spy, ~1.4x, band-binding on the 1.6x cap and the single biggest active drag at -11.8bps inception — another financials name leans into the gate. top-5 87.4pct incl the 76.6pct spy core. cme the name to watch — down 14.51pct, ~549bps off the -2000 stop, no other name inside 500. beta 0.9066 on the floor. no rejects, no halts, no breaks. back to you, chair.
FRAME — 06-29. Book's read for the open: NAV $969.4k, 11 active against the 18-name floor, cash 1.66% under the 2% line, beta 0.9066 pinned dead on the 0.90 floor with zero headroom below. SPY core 76.6%, CME -14.5%. The frame sets what we can afford to do today — start with the regime.
Priya — macro regime read. Daniel — sector and factor stance off that. Then I'll set the risk envelope from the loss path. Margaret — themes you're watching into DISCUSS.
No vote this phase. Abstain on the frame; I vote the risk seat when names are called.
VOTE: abstain
Rates: 10yr backed off to 4.40 (from 4.50), and reals eased to 2.19 — off the 2.29 cycle high but still restrictive. Low-vol stays ON: this is a pullback within the squeeze, NOT through 1.90. 2s10s 31bps, and the steepener remains 2y-led — 2y rolled 4.24→4.09 as cuts get pulled forward, 10y barely moved. Cuts, not growth. Funds 3.63 parked; FOMC posture is patient — no live cut priced near-term, May CPI index still grinding up (333.98).
Dollar/oil: USD firm at 120.4. WTI $78.94, holding the break under $80 (from $84.65) — energy hedge deflating, which helps headline but does nothing for shelter/services stickiness. China stays a deflationary drag, not a reflation impulse.
Credit/vol: OAS crept back to 278 (from 263 cycle-low, 271 last week) — second week off the lows, still complacent but I'm watching the drift. VIX 18.4, equity-vol elevated, not credit.
Tilt unchanged: quality over junk, cash-flow-today over multiple, low-vol bias intact. Reals easing 10bps is the only real change — noted, not acted on. Book pinned beta 0.9066 on the floor; honest beta comes from a cheap β≥1.15 quality cyclical, not the ETN lever.
Target gross: ~98% (cash 1.66% is too thin — rebuild a 2-3% SGOV residual; don't push gross higher into a 0.90-floor beta-constrained book). The binding constraint this week isn't exposure, it's structure: 11 names vs an 18 floor, beta pinned at 0.9066 with zero headroom below, and a 76.6% SPY core doing 84% of our risk. Every defensive add I want makes the floor worse. So the factor sponsorship is conditional.
Factor tilt I sponsor: quality cash-flow-yield as the core, but the marginal name MUST be β≥1.10 quality-cyclical. Same wall I've held since 06-18 — we can only seat low-vol ballast (GILD's 2nd leg) paired with a high-beta unlock. Priya's frame holds: reals 2.19 still restrictive, low-vol ON, this is a pullback not a turn through 1.90. So low-vol stays the bias — but funded by the right pair, not faked off the ETN.
Sectors — lean in: Financials (already +4.9pp, the active engine — V/SPGI led; ex-CME it's working) and Industrials quality-cyclical (FDX/ETN, our beta carriers). Lean out / fix: IT is -7.2pp underweight and cost us -79bps since inception and -9.8bps last meeting — that's the single biggest active drag and it's a non-position. The honest read: our underweight-IT, overweight-defensive structure is the whole gap-to-target. Where I want the book to move: toward the 18-name floor with quality-cyclicals that earn beta AND close the IT gap — a quality megacap-tech name (not junk-beta) does double duty. CME (-29.5bps active, β0.26) is the funding source — it's a dead-money low-vol financial dragging both return and the name count without paying for it.
2x2 for the marginal name this week:
| β≥1.10 (cures floor) | β<0.90 (breaks floor) | |
|---|---|---|
| closes IT gap | TOP PRIORITY — file | skip, can't seat |
| defensive/other | seat + unlock GILD leg | park, pre-committed |
Top-left is where I want Margaret to hunt: a quality IT/tech name with real beta. That's the one add that fixes structure, beta, and the largest active drag in one trade.
Triggers carry: OAS>350 → FDX first cyclical cut (OAS 278 now, off the lows, watching); reals<1.90 + 10yr<4.30 → ease low-vol, migrate ETN right-side.
Risk envelope — 06-29.
The one hard gate is the single-name cap, 0.5%–3.5% of NAV. Nobody's tripping it: V is the closest at 3.25% ($31.5k), FDX next at 2.54%. We've got ~25bps of room on V before the gate bites — fine, but it's our biggest single name, so any V add is a deliberate concentration choice, not a fill.
The concentration the gate WON'T catch is structural and you've heard it: 11 names against an 18 floor, top-5 at 87.4% — but that's SPY-core distortion, real top-5 of actives is thin. The book is 76.6% one ticker (SPY). The active sleeve is ~22%, and inside it Financials run 17.9% / 1.4x SPY — the dominant tilt and the biggest inception drag at -67bps, led by CME -14.5% (~550bps from the -2000bps stop-review). That's the judgment call this week: we keep adding to the wrong sector or we don't.
What makes me call a flag mid-week: CME through ~$203 (the stop-review line), OAS through 350, or any name pushing V past 3.4%.
VOTE: abstain
My themes haven't moved, the structure has. The core thread is still cash-flow yield where the tape divorced price from the franchise, run through a hard quality filter while reals at 2.19 punish junk. Patent-cliff pharma is the deepest vein I'm mining — BMY at fwd ~9x on $14B OCF, GILD at 39% op margin and ROE 43%; both are tape, not thesis. Deep-value Staples (GIS working +4.6%) and the high-beta-quality-cyclical lane (FDX, now filled and +1.6%) round it out. The unresolved item is CME — down 14.5%, -36bps, my worst name. At β0.26 and a fresh low I owe the room an honest thesis-vs-tape verdict before I keep defending it; that's my homework. Watchlist off the book: ABBV (re-rated, want a real pullback), GS (want a dislocation not the high). I won't chase what already moved.
PROPOSE — 06-29. Floor's open.
Table the names you'll defend today, in order: Margaret, Daniel, Priya, then me. Put up conviction, not a wish list — a few names debated properly, with a why-now and a stop, and we vote them this session.
Two structural facts frame what seats: beta's pinned dead on the 0.90 floor with zero headroom below, so any defensive add re-breaks it unless paired with a β≥1.15 name; and cash is 1.66%, under the 2% line, so a pure-cash open thins it further. The book gets built across meetings — not all today.
Margaret, you're up. VOTE: abstain
My themes haven't moved; the structure finally has. The high-beta quality leg the campaign has waited on since 06-18 landed this week — and it's GS, the same name I refused to chase on 06-22. Then it sat $1,096.56 at its 52-week high, up 22% over the window — a chase, and I passed. Now Goldman closed $1,019.61 on 06-26, down 4.3% on the day and about 8% off the $1,125 high, on a market-wide risk-off move with no GS-specific crack on the wire. That is tape divorced from franchise — the real dislocation I held out for, not the top.
The franchise checks out on primary numbers: FY25 net income $17.18B (up from $14.28B), diluted EPS $51.32, equity $125B, ROE ~14% (10-K via SEC XBRL). Forward 17.3x, P/B 2.76x on a 14%+ return — reasonable, not the ABBV chase. One caveat I'll name out loud: GS operating cash flow screens negative, but that's a broker-dealer balance-sheet artifact; net income is the right earnings read here. Beta 1.291. The capital-markets backdrop is constructive — US share sales hit a record ~$251B at midyear, a strong issuance tape that feeds the IB and equities lines behind four straight double-digit beats.
So I'm filing the PAIR I've pre-committed to since 06-18: GS 2.5% open + GILD 1.02%→2.0% resize. The basket clears live — would_clear true, zero breaches, beta 0.9066→0.9068, 11→12 names, top-5 down to 84%. GS solo clears too. One high-beta name carries GILD's β0.33 leg over the 0.90 floor — the structural wall, honestly cleared. ABBV is OFF the table: it ran to its 52-week high $253.35 on 52.6M shares 06-26, +13.6% on the window — that's the chase I won't make, same discipline.
Two things I flagged for the chair. One, GS prints Q2 07-14 (est $13.64), 15 days out — outside the freeze. This is NOT the FDX night-before binary I refused; I'm buying 8% off the high with two weeks of runway, and the beat streak plus the record issuance tape skew the binary favorably. Two, funding: the basket as tested holds cash at 1.66%, under the 2% floor. If the room wants the SGOV residual rebuilt this session, fund GS partly from an SPY-core trim rather than cash — I'll defer the mix to Daniel's sizing call; the structure holds either way. Stop: kill if Q2 misses on a franchise line (IB/trading revenue down y/y, not a provision), if ROE compresses structurally below ~11%, or -15% relative.
Backing Margaret's GS unlock — restructured so the funding does double duty. I filed the 3-leg basket this morning: #66 GS 2.5% open + #67 GILD→2.0% resize + #68 CME close. The only change from Margaret's filing is the funding source: fund GS from the CME close, not cash.
Why the restructure. Margaret's GS+GILD-from-cash basket clears, but it leaves cash at 1.66% — under the 2% floor, the live breach Iris flagged at the open. Funding from the CME close cures that in the same trade. I also tested an SPY-core trim to fund GS — it breaks BOTH the cash floor (residual → 0%) and the SPY single-name cap. CME is the honest source.
Gate, all three legs together (live): would_clear true, zero breaches. Book beta 0.9066 → 0.9011 (on-band, cleanly above the 0.90 floor). Cash 1.66% → 3.87% (SGOV residual rebuilt, inside [2%,10%]). Top-5 84%, 11 names.
GS (#66): ~$1,020, ~9% off the $1,125 52w high on a market-wide risk-off — no franchise crack on the wire. Same name I refused at $1,096 AT its high on 06-22; got the dislocation this time. β1.291, PE 18.6/fwd 17.3, P/B 2.76, ROE 14.6%, EPS +24% YoY — cheap-ish quality cyclical, not junk-beta. Q2 prints 07-14, ~15 days out, outside the freeze. Expected excess ~+50bps, 1.0–1.5R. STOP: miss on a franchise line (IB/trading rev down y/y, not a provision), ROE <~11%, or -15% rel.
GILD (#67): the pre-committed second β0.33 leg — only seats paired with a β≥1.15 name. GS is that name; its dollars carry GILD over the floor. 39% op margin, ~$10B OCF, ROE 43%, fwd ~15x. Low-vol ballast Priya's frame rewards. Conv 4.
CME (#68): β0.26 dead-money financial, -29.5bps active since inception, -14.5% since entry — my standing cut candidate since 06-18. Wire shows a TD Cowen PT trim, no broken-franchise crack: a slow bleed, the textbook recycle. Crystallizes ~-$3.6k realized, a loss already on the mark.
Tradeoff on the record: this holds the book at 11 vs the 18-name floor — a 1-in-1-out, not a headcount advance. I take it: curing a live cash breach + upgrading a β0.26/-29.5bps drag to a β1.29 quality name beats a paper count gain that leaves us under the cash floor. The 18-name campaign resumes next session with a clean residual to fund from.
Frame (Priya 06-29): reals 2.19 (off the 2.29 cycle high) still restrictive, 10yr 4.40, OAS 2.78, VIX 18.4 — low-vol ON, 2y-led steepener. GS = quality cyclical on a dislocation; GILD = low-vol ballast. To the vote.
No single-name proposal from me — my lane is whether the GS+GILD+CME basket on the floor is structurally honest and frame-fit. It is, on both counts; I endorse it.
Frame, verified live (06-29): reals 2.19 — off the 2.29 cycle high but still restrictive, a pullback inside the squeeze, NOT through 1.90. 10yr 4.40, 2s10s 31bps still 2y-led (2y 4.24→4.09; cuts pulled forward, not growth priced). Oil $78.94 holds under $80 — hedge deflating, helps headline not shelter. OAS 2.78, second week drifting off the 2.63 lows — complacent but this is my one watch item, my first real tell toward the >350 cyclical-cut trigger. VIX 18.4 is equity-vol, not credit. Low-vol stays ON.
Why the basket fits: GS is a cheap-ish high-quality cyclical (β1.29, PE 18.6/fwd 17.3, ROE ~14.6%, EPS +24% YoY) caught ~8-9% off its high in a market-wide risk-off with no franchise crack on the wire — quality on a dislocation, not junk-beta. The one β≥1.15 name carries GILD's β0.33 low-vol leg over the floor — the honest beta cure I've held to since 06-18, structure not faked beta off the ETN lever into restrictive reals. CME is the β0.26, -29.5bps-active dead-money financial — the deepest active detractor in the book and my standing recycle candidate; funding GS off the CME close cures the live sub-2% cash breach (1.66%→3.87%) in the same trade and rebuilds the SGOV residual. Daniel's restructure is the right one: SPY-trim funding breaks both the cash floor and the SPY cap; CME is the clean source.
On the record: this holds the book at 11 vs the 18-name floor — a 1-in-1-out, not a headcount advance. I take it. Curing a live cash breach plus upgrading a β0.26/-29.5bps drag to a β1.29 quality name beats a paper count gain that leaves us under the cash floor. AYE on the basket.
Risk seat — the 3-leg basket (GS 2.5% open / GILD 1.02%→2.0% / CME close). I don't propose names; I read the gate fresh and put the loss on the table before the vote.
Gate, live and clean. I re-ran check_basket_risk on all three legs together: would_clear true, zero breaches. Beta 0.9066→0.9011 — off the 0.90 floor and on-band cleanly, the first real headroom we've had in weeks. Cash 1.66%→3.87% — that cures the sub-2% cash-band breach I flagged at the open, in the same trade. Top-5 84%, 11 names held. CME funds GS; nothing else moves.
GS dislocation is real, not the high Margaret refused on 06-22. Verified on the live feed: $1,096.56 on 06-18 to $1,019.61 on 06-26 — about 7% off in a week on 4.0M shares, twice the usual tape, selling with the financials, no franchise crack on the wire. β1.291, fwd PE 17.3, ROE 14.6%, EPS +24% YoY. Cheap-ish quality cyclical, the high-beta unlock the campaign waited on since 06-18 — not junk-beta.
What we lose. GS at 2.5% is about $24.2k. If it gaps -10% on the 07-14 Q2 print — 15 days out, outside the earnings freeze — we lose roughly $2.4k, about 25 bps of NAV. A -15% move to Margaret's stop is ~$3.6k, ~37 bps. Bounded, and the IB/equities franchise survives a price event like that. I'll wear it.
CME close is a loss already on the mark, not new risk. Crystallizing ~-$3.6k realized on a β0.26 name that's bled -29.5 bps active since inception — recycling dead money into a β1.29 quality name is the honest upgrade. GILD's second leg seats only because GS dollars carry its β0.33 over the floor; that's the structure working as designed.
One flag carries, not a veto. This holds the book at 11 vs the 18-name floor — a 1-in-1-out, not a headcount advance. The minimum-holdings rule isn't a gated veto and the basket improves cash and beta, so I won't kill it over a count that's already off-policy. On the record, the campaign needs to add names next session toward 18, now with a clean residual to fund from.
VOTE: approve
DISCUSS — 06-29. Phase is open. The work now is to stress the basket before the vote, not relitigate the frame. The 3-leg basket cleared the gate when I read it: would_clear true, beta 0.9011 off the floor, cash cured to 3.87%. The open questions for the room are GS's downside on the 07-14 print and whether closing CME at a realized loss is the honest funding. Margaret — you're up. Walk the GS thesis and the stop.
The trade — 3-leg basket, all filed (#66/#67/#68): GS 2.5% open, GILD 1.02%→2.0% resize, CME close. Catalyst: GS ~$1,020, ~9% off the $1,125 high on a market-wide risk-off — no franchise crack on the wire. β1.291, fwd 17.3, ROE 14.6%, EPS +24% YoY. Q2 prints 07-14, 15 days out, outside the freeze. Same name I refused at the high 06-22; got the dislocation. Stop: miss on a franchise line (IB/trading rev down y/y), ROE <~11%, or -15% rel. Why this size / structure: fund GS from the CME close, not cash — cures the 1.66% cash-floor breach in the same trade (cash→3.87%), beta 0.9066→0.9011 on-band, top-5 84%. CME is β0.26/-29.5bps dead-money, my standing cut since 06-18. One trade cures the breach AND upgrades the worst drag to a quality cyclical. Tradeoff owned: holds 11 names vs 18 floor — 1-in-1-out, no headcount advance. I take it. open for discussion.
Endorsing Daniel's restructure — funding GS off the CME close, not cash, is the honest source: it cures the 1.66% floor breach AND recycles a β0.26, -29.5bps dead-money financial into a β1.29 quality cyclical in one trade. That's an upgrade, not just a swap.
On Iris's downside question: I'm buying GS ~$1,020, ~9% off the $1,125 high, on a market-wide risk-off with no franchise crack on the wire — tape divorced from the franchise, the dislocation I refused at $1,096 on 06-22. Franchise (FY25 SEC XBRL): NI $17.18B from $14.28B, dil EPS $51.32, ROE ~14.6%, fwd 17.3x, P/B 2.76. Cheap-ish quality, not junk-beta.
The one tension stays the 07-14 Q2 print, 15 days out — outside the freeze, and I'm buying off the high WITH runway, not the FDX night-before binary. Four straight beats, record ~$251B midyear US share issuance feeds IB/equities. Stop: Q2 miss on a franchise line (IB/trading rev down y/y, not a provision), ROE structurally <~11%, or -15% rel. I'm AYE.
Frame holds — 7th straight week, verified live: reals 2.19 off the 2.29 cycle high but still restrictive, 10yr 4.40, 2s10s 31 still 2y-led (cuts pulled forward, not growth), oil $78.94 under $80, OAS 2.78 — second week drifting off the 2.63 lows, my first real tell toward the >350 trigger. Low-vol stays ON; the reals pullback is a squeeze breather, not through 1.90. On the basket: GS is a β1.29 cheap-quality cyclical bought ~9% off the high on a market-wide risk-off, not junk-beta into reals — frame-fit. GILD's β0.33 leg seats honestly carried by GS dollars. Funding from the CME close cures the live cash-floor breach in the same trade — the honest source, not faked beta off the ETN. AYE.
My loss numbers stand from this morning — no change in conditions since I read the gate. GS 2.5% ≈ $24.2k exposure; a -10% gap on the 07-14 print (outside the freeze) costs ~$2.4k / ~25bps NAV, a -15% stop trip ~$3.6k / ~37bps. Bounded, and the IB/equities franchise survives a price event. The basket cures what I flagged at the open: cash 1.66%→3.87% back inside the floor, beta 0.9066→0.9011 off the floor cleanly, zero gate breaches. CME close crystallizes ~-$3.6k already on the mark — a realized loss, not new risk, recycling a β0.26/-29.5bps drag into β1.29 quality. The standing flag carries: 11/18 names holds — a 1-in-1-out, not a headcount advance. Not gated, on the record, and not a veto. VOTE: approve.
06-29 meeting brief, no fills yet — floor is the 3-leg basket, not the fdx headline (fdx already seats 2.54%, +1.57%/+11.7bps active). if voted: cme close leads (-95 sh @ ~225, ~-$3.6k realized) to raise cash and fund gs 2.5% (~24 sh @ ~1019.61, clean clip on 2-4m vol) + gild resize to 2.0% (~+79 sh @ ~123.84). curing the 1.66% cash floor -> ~3.87%, beta 0.9066->0.9011, book stays 11 names. waiting on the chair for the gs working style — limit or vwap and a cap off the 1019.61 mark. cme/gild i work vwap. no breaks.
VOTE — 06-29, chairing. The docket names #64 (FDX), but FDX already seats 2.54%, +1.57%. The live floor is the 3-leg basket — GS 2.5% open / GILD 1.02%→2.0% / CME close — and that is what I'm calling. Voting order: Margaret, Daniel, Priya, Iris. Cast it.
Gate fresh, re-read this round: would_clear true, zero breaches. Beta 0.9066→0.9011, off the floor cleanly. Cash 1.66%→3.87% — cures the sub-floor breach I flagged at open. Top-5 84%, 11 names.
Loss path stands. GS 2.5% ≈ $24.2k exposure; a -10% gap on the 07-14 print (outside the freeze) costs ~$2.4k / ~25bps NAV, a -15% stop trip ~$3.6k / ~37bps. Bounded, and the IB/equities franchise survives a price event. CME close crystallizes ~-$3.6k already on the mark — a realized loss, not new risk — recycling a β0.26/-29.5bps drag into a β1.29 quality name.
Standing flag carries: 11/18 name count holds — 1-in-1-out, not a headcount advance. Not gated, on the record. I won't veto a basket that cures the cash floor and upgrades a dead-money name. VOTE: approve
This is the basket I filed and Daniel restructured the right way — GS funded off the CME close, not cash, so the trade cures the 1.66% floor breach AND recycles a β0.26, -29.5bps dead-money financial into a β1.29 quality cyclical in one move. That's an upgrade, not a swap. GS is the dislocation I held out for: closed $1,019.61, ~9% off the $1,125 high on a market-wide risk-off with no franchise crack on the wire — the same name I refused to chase at $1,096 at its high on 06-22. FY25 (SEC XBRL): NI $17.18B, dil EPS $51.32, ROE ~14%, fwd 17.3x, P/B 2.76 — cheap-ish quality, not junk-beta. GILD's second 1.0% finally seats because GS carries its β0.33 over the 0.90 floor — the wall I've held since 06-18, honestly cleared. The one tension I own openly: Q2 prints 07-14, 15 days out, but I'm buying 8% off the high with runway, not the night-before binary I refused on FDX, and the stop is set — miss on a franchise line, ROE structurally <11%, or -15% rel. Aye.
VOTE: approve
This is the 3-leg basket I restructured and filed this morning (#66 GS 2.5% open / #67 GILD→2.0% / #68 CME close), and nothing in the room has moved the numbers since: gate clears clean, beta 0.9066→0.9011 on-band off the floor, cash 1.66%→3.87% back inside band — funding GS off the CME close cures the live cash breach AND recycles a β0.26/-29.5bps dead-money financial into a β1.29 quality cyclical on a real ~9% dislocation, not the high I refused on 06-22. Iris's loss path is bounded (-10% gap ~25bps, -15% stop ~37bps), GS Q2 prints 07-14 outside the freeze, and Priya's frame holds 7th week — low-vol ON, GILD ballast seats paired. I own the tradeoff on the record: 1-in-1-out holds the book at 11 vs the 18 floor, but curing a cash-floor breach and upgrading beta-quality beats a paper headcount gain under the floor. VOTE: approve
No single name from me — my lane is whether the 3-leg basket (GS 2.5% open / GILD→2.0% / CME close) is structurally honest and frame-fit. It is, on both counts. Frame holds verbatim a 7th straight week: reals 2.19 off the 2.29 cycle high but still restrictive (a pullback, NOT through 1.90), 10yr 4.40, 2s10s 31 still 2y-led (cuts pulled forward, not growth), oil $78.94 under $80, OAS 2.78 — second week drifting off the 2.63 lows, my first real tell toward the >350 cyclical-cut trigger. Low-vol stays ON.
Structure: GS β1.29 ~9% off its high on a market-wide risk-off is a quality cyclical on a dislocation, not junk-beta — it carries GILD's β0.33 low-vol leg honestly. CME close is the honest funding source: it cures the live 1.66% cash-floor breach AND recycles a β0.26/-29.5bps dead-money financial in one trade. Gate clears clean — beta 0.9066→0.9011 on-band off the floor, cash→3.87% back inside band, zero breaches. This is the beta cure I've held since 06-18: one quality cyclical funds the low-vol leg, no faked beta off the ETN into restrictive reals. AYE.
I called this vote from the chair and the numbers haven't moved since I read the gate fresh this morning: basket would_clear true, zero breaches, beta 0.9066→0.9011 off the floor and on-band cleanly, cash 1.66%→3.87% — the CME close cures the sub-floor cash breach I flagged at the open. Loss path: GS 2.5% ≈ $24.2k exposure; a -10% gap on the 07-14 print (outside the freeze) costs ~$2.4k / ~25bps NAV, a -15% stop trip ~$3.6k / ~37bps — bounded, and the IB/equities franchise survives a price event. CME close crystallizes ~-$3.6k already on the mark, a realized loss not new risk; recycling a β0.26/-29.5bps dead-money drag into a β1.29 quality name is the honest upgrade. The 11/18 name count holds — a 1-in-1-out, not a headcount advance — which I carry as an info flag, not a veto. Bounded and acceptable, and it cures a live cash breach. VOTE: approve
The trade — GILD #67, the resize leg of the basket: 1.02%→2.0%, the pre-committed second β0.33 low-vol leg I've held parked since 06-18. It only seats paired with a β≥1.15 quality name — GS is that name, and GS dollars carry GILD's β0.33 drag over the 0.90 floor. Solo it vetoes (0.899); in the basket it clears at 0.9011, on-band off the floor.
Catalyst: not a single-name event — GILD is ballast, not a catalyst trade. 39% op margin, ~$10B OCF, ROE 43%, fwd ~15x. It's the low-vol anchor Priya's frame demands (reals 2.19 still restrictive, low-vol ON a 7th week). The catalyst it's tied to is structural: it's the leg that lets us add quality cyclical (GS) without breaching the beta floor.
Stop: franchise stop, not a tape stop — kill if op margin compresses structurally below ~30% or OCF runs sub-$8B. -15% rel as the mechanical backstop.
Why this size: 2.0%, not more — it's ballast, not a conviction high-beta swing. The whole point of GILD is to be the β0.33 counterweight that buys us room to take GS's β1.29 without tripping concentration or beta caps. Doubling it past 2% would tilt the book low-vol-heavy and waste the GS unlock. 2.0% is the size that pairs, not the size that leads. Gate confirms the full basket clears at this weight — zero breaches, top-5 84%, cash cured to 3.87%.
open for discussion.
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjfJtpUgQe5ru7pvDv'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjh54CuBXmjnqu6ied'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjiuSau429mHTjyvCu'}
[error] agent ops failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjkHHdKrTcJHwQnP8n'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjmnpd4iDgt4Z1sXD1'}
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjoHN1J6LGc74DmHBS'}
[error] agent strategist.daniel failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjpeDfnupuNPGAW8Xz'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjqu82LmJkm5dFe9d2'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjsLwPqPUbvQxjLajt'}
[error] agent strategist.daniel failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjumnu57LuUQ3wvtDe'}
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjwr4FyZEXJ3R9aqEs'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjyG8orqMpG8E4Jovy'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgjzjSkuAHn5G97KRVs'}
[error] agent ops failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgk3wRXiqpDBiCMAXYZ'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgk7uHu8Zsxhs3pcLit'}
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkBWaoRea61rYmbDvE'}
[error] agent strategist.daniel failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkFN1VtkGB978G5xnz'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkHhegvHi7eaXTU3G8'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkKGAhGt7muVjNFgEr'}
[error] agent strategist.daniel failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkN36dc6URgaziLKqB'}
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkQmoWXpzaba33cmTi'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkS5gaJ91Uz8BDfbxb'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkTktXGF7Mkb25h2kE'}
[error] agent ops failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkVJQqjuZGQJt76d3w'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkWiF1SHyR68L1ND3n'}
[error] agent fundamentalist.margaret failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkY855yYJZiY4DoNxS'}
[error] agent strategist.daniel failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkZcNQEQUg7MCy6Fxp'}
[error] agent macro.priya failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkau1geKJ7Zg6Rmv91'}
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkcCPuF4xPJyn387w8'}
VETOED — CME 0.00% did NOT fill: minimum holdings — 10 positions (min 18). Resize, pair an offsetting name, or hold it for a future session.
[error] agent risk.iris failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkdsbn1Z3ve27e4xxx'}
[error] agent editor.lena failed: BadRequestError: Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'You have reached your specified API usage limits. You will regain access on 2026-07-01 at 00:00 UTC.'}, 'request_id': 'req_011CcXgkfKQzKCEumdN3cM3r'}